Literature DB >> 143884

Influence of etiology of atrial fibrillation on incidence of systemic embolism.

R C Hinton, J P Kistler, J T Fallon, A L Friedlich, C M Fisher.   

Abstract

Atrial fibrillation is well known to increase greatly the risk of systemic arterial embolism in patients with mitral valve disease. In light of the clinical frequency of embolism in patients with atrial fibrillation due to other types of heart disease, a study was made of embolic occurrences in 333 autopsy patients with atrial fibrillation associated with various kinds of heart disease. Considering only symptomatic emboli with pathologic or surgical confirmation, embolism occurred in 41% of patients with mitral valve disease, 35% of those with ischemic heart disease, 35% of those with coexisting mitral and ischemic heart disease and 17% of those with "other" types of heart disease. Embolism was found in only 7% of a control group of 58 autopsy patients with ischemic heart disease without atrial fibrillation. These findings suggest a high risk of embolism from atrial fibrillation of any origin, but particularly from that caused by ischemic heart disease and mitral valve disease.

Entities:  

Mesh:

Year:  1977        PMID: 143884     DOI: 10.1016/0002-9149(77)90064-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.

Authors:  Alexander C Perino; Jun Fan; Susan K Schmitt; Mariam Askari; Daniel W Kaiser; Abhishek Deshmukh; Paul A Heidenreich; Christopher Swan; Sanjiv M Narayan; Paul J Wang; Mintu P Turakhia
Journal:  J Am Coll Cardiol       Date:  2017-07-04       Impact factor: 24.094

Review 2.  Anticoagulation Resumption After Stroke from Atrial Fibrillation.

Authors:  Brian Mac Grory; Shane Flood; Matthew Schrag; Maurizio Paciaroni; Shadi Yaghi
Journal:  Curr Atheroscler Rep       Date:  2019-05-20       Impact factor: 5.113

Review 3.  Is anticoagulation therapy underused in elderly patients with atrial fibrillation?

Authors:  F M Turazza; M G Franzosi
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

Review 4.  Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.

Authors:  J R Stratton
Journal:  West J Med       Date:  1989-08

Review 5.  Assessment of the risk-benefit ratio for antiarrhythmic drug use.

Authors:  R W Campbell
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

6.  The drug treatment of atrial fibrillation.

Authors:  K S Channer
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

7.  Atrial fibrillation and embolism.

Authors:  J A Milliken
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

8.  Left atrial thrombi in non-rheumatic atrial fibrillation: assessment of prevalence by transesophageal echocardiography.

Authors:  J Brown; D B Sadler
Journal:  Int J Card Imaging       Date:  1993-03

9.  The role of echocardiography in the investigation of focal cerebral ischaemia.

Authors:  P J Burnett; J R Milne; R Greenwood; M R Giles; J Camm
Journal:  Postgrad Med J       Date:  1984-02       Impact factor: 2.401

Review 10.  Prevention of embolic complications in nonvalvular atrial fibrillation in the elderly.

Authors:  F R Lake; P L Thompson
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.